The EMBOLD study evaluated relutrigine for patients with SCN2A and SCN8A developmental and epileptic encephalopathies
Acromegaly, a rare chronic endocrine disorder caused by excess growth hormone, is seeing promising advances in treatment development
VitiPure serves as essential solubilizers, emulsifiers, and bioavailability enhancers in drug formulations
Growing patent filings and tier-2 innovators reflect expanding national research base
Sun Pharma to set up Rs. 3,000 crore greenfield formulations facility in MP
AEF0217 is a first-in-class CB1 receptor signaling-specific inhibitor
The PCR-based test, delivered via Roche’s cobas liat system, allows results to be obtained during a patient consultation in GP practices and Emergency Rooms
The acquisitions merge DatCard and Sorna’s expertise in clinical data sharing with Avandra’s de-identified patient data aggregation platform
Health Canada’s approval was based on a comprehensive evaluation of analytical, nonclinical, and clinical data
Subscribe To Our Newsletter & Stay Updated
